Last reviewed · How we verify
NCT06592898
Different Squatting Modes in the Rehabilitation of Patellofemoral Pain Syndrome
NA trial testing straight leg raise in Patellofemoral Pain Syndrome in 84 participants. Completed in 1 December 2023.
1 November 2023
Quick facts
| Lead sponsor | Peking University Third Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 84 |
| Start date | 1 October 2023 |
| Primary completion | 1 November 2023 |
| Estimated completion | 1 December 2023 |
| Sites | 1 location across China |
Drugs / interventions tested
- straight leg raise
- wall squat
- direct squat
- wall squat assisted by elastic bands
Conditions studied
- Patellofemoral Pain Syndrome — all drugs for Patellofemoral Pain Syndrome →
Sponsor
Peking University Third Hospital
Who can join
Eligibility, any sex, with Patellofemoral Pain Syndrome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study take 84 patients with Patellofemoral Pain Syndrome in Peking University Third Hospital during January to September in 2023 as subjects, aiming to explore the efficacy and intervention effects of three different static squat modes including straight leg raise, wall squat, direct squat and wall squat assisted by elastic bands for patients with PFPS, in order to providing theoretical basis and effective guidance for future home rehabilitation of patients with PFPS combined with mobile health.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06592898
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Patellofemoral Pain Syndrome
Currently open trials in the same condition.
- NCT07318987 — EFFECT OF SAPHENOUS NERVE RELEASE ON PATIENTS WITH PATELLOFEMORAL PAIN SYNDROME · NA · recruiting
- NCT06913426 — Effects of Pelvic Tilt Exercises Along With Hip and Knee Focused Exercises on Patients With Patellofemoral Pain Syndrome · NA · active not recruiting
- NCT06875804 — Compressive Myofascial Release of the Vastus Lateralis on Lateral Patellar Tracking in Patellofemoral Pain Syndrome · NA · recruiting
- NCT06598618 — Comparison of IASTM and Muscle Energy Technique in Patellofemoral Pain Syndrome. · NA · recruiting
- NCT06566950 — BFR Training on Muscle Morphology · NA · recruiting
Other Peking University Third Hospital trials
Trials by the same sponsor.
- NCT07532421 — Probiotic Intervention on the Development of Allergic Diseases in Infants Exposed to Antibiotics Early in Life · NA · not yet recruiting
- NCT07470255 — Detection of Diabetic Foot Skin Damage Using Plantar Mechanical Parameters · not yet recruiting
- NCT07453381 — Multisensor Wireless Pressure Microcatheter For Microvascular Function Assessment In ANOCA/INOCA Patients: A Prospective · not yet recruiting
- NCT07452354 — AI-Based Diabetic Foot Recurrence Cohort · not yet recruiting
- NCT07423819 — Sports Rehabilitation Therapy for Knee Joint Sports Injuries: A Case Study of Anterior Cruciate Ligament Injury and Pate · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06592898 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Peking University Third Hospital
- Last refreshed: 19 September 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06592898.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing